CLINICAL AND DIAGNOSTIC VALUE OF CHANGES IN IMMUNOLOGICAL STATUS IN THE DEVELOPMENT OF ARRHYTHMIAS IN PATIENTS WITH MYOCARDIAL INFARCTION

Abstract

In recent years, ischemic heart disease (IHD) ranks first among the causes of death in developed countries [6]. The acute period (^ -myocardial infarction in 90-95% of cases is complicated by the development of cardiac arrhythmias, which are the most common cause of death at the prehospital stage, and at the hospital stage - the second most frequent cause of death (^ -myocardial infarction.